DF-006

N/A

Report date: 2026/04/08 16:01:08
NME

Base Information

Drug NameDF-006
Drug Alias NameDF-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-protein kinase 1 agonists
TargetsAlpha-protein kinase 1
Therapy Area/IndicationsLiver NeoplasmsHepatitis B, ChronicHepatitis B +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Drug Farm Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesXiamen Amoytop Biotech Co LtdShanghai Drug Farm Biotechnology Co LtdZhejiang Yao Yuan Biotechnology Ltd
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsHepatitis B, ChronicHepatitis B +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A